Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

FDA classifies optical breast imaging device as Class III

The FDA has notified Imaging Diagnostic Systems that the review of its Section 510(k) premarket notification application of its CTLM system has been completed and categorized as a Class III device requiring a premarket approval (PMA) application.

FDA clears GEs compact CT

The FDA has cleared GE Healthcares Optima CT660, a compact CT system providing low-dose scanning.

Colorado orders Heart Check to pay $3.2M fine

The X-Ray Certification Unit of the Colorado Department of Public Health and Environment has ordered Heart Check America to pay a $3.2 million penalty, the largest ever imposed by the states radiation program.

AHRMM: Technology, cost analyses key to supply chain management

BOSTONA faltering economy, coupled with loss of consumer confidence and the added pressure of healthcare reform has created a perfect storm in the healthcare industry; thereby, increasing the need for supply stream improvement to help manage costs, according to presenters Aug. 8 at the 2011 Association for Healthcare Resources & Materials Management (ARHMM) annual conference.

AAPM: Five steps to safer radiation therapy

A combination of well-known safety procedures could prevent most patient-harming errors in radiation therapy, according to a study presented at the annual meeting of the American Association of Physicists in Medicine (AAPM) and Canadian Organization of Medical Physicists, July 31 to Aug. 4 in Vancouver, Canada.

FDA gives nod to Toshibas 3T MR

Toshiba America Medical Systems has received FDA clearance for its Vantage Titan 3T open-bore MR system.

JACC: 82Rb myocardial flow reserve with MPI stratifies cardiac risk

Myocardial flow reserve quantified using rubidium-82 (82Rb) PET predicts hard cardiac events and major adverse cardiac events independent of the summed stress score and other parameters, according to research published Aug. 9 in the Journal of the American College of Cardiology. Therefore, the researchers recommended that routine assessment of 82Rb PET-quantified myocardial flow reserve could improve risk stratification for patients being investigated for ischemia.

JNM: 18F PET can be used in clinical practice for neuroimaging

18F-florbetaben had high sensitivity for Alzheimers disease (AD), clearly distinguished patients with frontotemporal lobar degeneration (FTLD) from AD and provided results comparable to those reported with 11C-Pittsburgh Compound B in a variety of neurodegenerative diseases, according to a study in the August issue of the Journal of Nuclear Medicine.

Around the web

To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.